Introduction
In recent decades, the isolation of different types of stem cells and their use in human and veterinary regenerative medicine has been highly regarded. Recent advances in stem cell research have provided new hopes for the treatment of diseases and disorders that have not so far been remediable. Thus, the isolation of various types of stem cells, including embryonic and adult, has attracted the attention of many researchers. Repair and regeneration of articular cartilage provides a substantial challenge in regenerative medicine, due to the high degree of morphologic and mechanical complexity intrinsic to the hyaline cartilage (Somoza et al., 2014) .
Adipose tissue of adult animals is a potential source of mesenchymal stem cells (MSCs) for tissue engineering and regenerative medicine, which could be used in the treatment of musculoskeletal diseases in veterinary medicine (Baksh et al., 2004) . Adipose tissue can be easily collected from different parts of the body (Vater et al., 2011) and the differentiation potential of equine MSCs derived from adipose tissue is almost the same as that of MSCs derived from bone marrow (Ribitsch et al., 2010) . Adipose tissue-derived MSCs (AT-MSCs) are capable of differentiating into multiple cell lines including bone, cartilage, tendon, and ligament in both in vitro and in vivo models (Zuk et al., 2001; Park et al., 2010) . The in vitro differentiation of equine MSCs into the cartilage upon different treatments ( Fortier et al., 1998; Worster et al., 2001; Hegewald et al., 2004; Arnhold et al., 2007; Stewart et al., 2007; Vidal et al., 2007; Giovannini et al., 2008 ) is being actively pursued. Thus, defining a more suitable condition for chondrogenic differentiation of equine ATMSCs is necessary.
Ligands of Notch and families of growth factors like transforming growth factor-beta (TGF-β), insulin-like growth factors (IGFs), and fibroblast growth factors (FGFs) play important roles for the formation of cartilage (Pogue and Lyons, 2006) . Bone morphogenic proteins (BMPs) are members of the TGF superfamily that regulate cartilage and bone formation. The BMP-6 and TGF-β 3 combination also has an anabolic effect on MSC pellet size (Vidal et al., 2008) . TGF-β induces the expression of chondrogenic markers such as BMP-6 that are involved in increasing the size and weight of the cultured pellets and producing matrix proteoglycans (Worster et al., 2000) . Due to the expression of many typical biomolecules of hyaline cartilage, such as collagen type II and aggrecan, the resulting differentiated tissue can be classified as cartilage (Somoza et al., 2014) . Therefore, the main objective of this study was to evaluate the effect of BMP-6 and TGF-β 3 on the in vitro chondrogenic differentiation of equine stem cells isolated from adipose tissue.
Materials and methods
The experimental protocols were approved by the Committee of Ethics and Animal Welfare of the School of Veterinary Medicine, Ferdowsi University of Mashhad, and were performed according to international guidelines for the care and use of experimental animals. In this study, 3 healthy crossbred mares were used for collection of adipose samples. All chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted.
Fat tissue sampling
Adipose tissue was collected from the region above the dorsal gluteal muscles. The horses were sedated with xylazine (0.7 mg/kg, i.v.) followed by subcutaneous injection of 2% lidocaine chloride with epinephrine using an inverted L-block. An incision of approximately 5 cm in length was performed parallel to and approximately 10 cm below the spinal column. Approximately 2-3 g of adipose tissue was collected and stored in a sterile 50-mL tube containing phosphate-buffered saline (PBS) plus penicillin-streptomycin.
Cell isolation, culture, and expansion
In order to eliminate possible contamination of blood samples taken from fat, samples were minced with a scalpel blade and washed in PBS solution containing 2% penicillin-streptomycin and 1% amphotericin B. Enzymatic digestion was performed by collagenase type I (0.1% plus 1% bovine serum albumin in PBS). Four milliliters of prepared enzyme was added to the fat content. The digestion container was incubated for 2 h at 37 °C and 5% CO 2 and was shaken vigorously every 10 min. The digested content was passed through a 70-µm cell strainer into Falcon tubes. The enzyme activity was neutralized by addition of Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) in the ratio of 3 parts medium to 1 part digestion medium. Samples were centrifuged at 600 × g for 5 min. After centrifugation, three phases of supernatant (suspended fat, adipose tissue, and PBS solution) were evacuated by a pipette. To the remaining pellet, 2 mL of DMEM-high glucose culture medium was added to resuspend and count the cells. The isolated cells were cultured in 75-cm 2 flasks with a concentration of 8 × 10 4 cells/cm 2 in DMEM containing 10% FBS, 100 µg/mL streptomycin, 100 IU/mL penicillin, and 0.1% amphotericin B and incubated at 37 °C with 5% CO 2 (passage zero). Every 3 days, the culture medium was replaced with fresh medium and suspended cells were removed from the flask. Cells at a confluency of approximately 80% were passaged using trypsinization by TrypLE solution (Invitrogen). Cell culture was continued until passage 3 (P3).
Experimental design for chondrogenic differentiation
To perform chondrogenesis experiments, 5 × 10 5 cells of P3 were transferred into a 15-mL Falcon tube to form a micropellet culture system. Cells were centrifuged for 5 min at 260 × g to form pellets. After 24 h, the supernatant was discarded and 2 mL of cartilage-inducing medium was used for treatment groups. Every 3-4 days, culture medium was replaced with fresh medium. Basic chondrogenic medium (BCM) contained DMEM-high glucose with 10% FBS, 100 µg/mL streptomycin, 100 IU/mL penicillin and 0.1% amphotericin B, 0.1 µM dexamethasone, 50 µM 2-phospho-L-ascorbic acid trisodium, 1% ITS (insulintransferrin-selenium), and 1 mg of bovine serum albumin. This study was designed in 5 groups with 9 replicates in each group: 1) control group: cells treated with basic medium containing DMEM-high glucose with 10% FBS, 100 µg/mL streptomycin, 100 IU/mL penicillin, and 0.1% amphotericin B; 2) cells treated with BCM without growth factors; 3) cells treated with BCM supplemented with 10 ng/mL growth factor BMP-6; 4) cells treated with BCM supplemented with 10 ng/mL growth factor TGF-β 3 ; and 5) cells treated with BCM supplemented with both TGF-β 3 and BMP-6 at a concentration of 10 ng/mL. Pellets were treated for 21 days at 37 °C and 5% CO 2 . After this period, histological evaluation by specific staining and the expression of cartilage-specific genes were studied.
Size determination and histological analysis of pellets
At the end of the differentiation period (day 21), the circumferences of all pellets in different groups were measured. Multiple sections of all pellets were prepared and stained with toluidine blue to evaluate proteoglycans, Alcian blue (pH 2.5) to evaluate glycosaminoglycan (GAG) deposition, Masson's trichrome to evaluate collagen filament formation, and hematoxylin and eosin (H&E) to evaluate the microscopic morphology of the pellet. To evaluate progression toward chondrogenic differentiation, all sections (5 replicates in each group) were examined by 3 histologists (blind observers). Each group received an overall score from 1 to 5 based on the stage of differentiation (1 for lack of differentiation signs and 5 for maximum differentiation). The means of the 3 histologists' observations were calculated and were used for data analysis. Progression of chondrogenic differentiation was scored based on some cartilage characteristics including cell morphology, lacunae formation, distance between cells, staining intensity of collagen, and proteoglycans and glycosaminoglycan in matrix. 2.5. Gene expression analysis RNA was extracted by the High Pure Kit (Roche, Germany). DNase treatment was included in the isolation protocol. The concentration and quality of RNA were evaluated with a NanoDrop spectrophotometer (Thermo Scientific, USA) and gel electrophoresis. One microgram of total RNA was reverse-transcribed into cDNA using the AccuPower RT Premix (Bioneer, South Korea) and 0.5 µg of oligothymidine in the presence of 1 mM dNTPs mix at 42 °C.
Specific primers for PCR amplification of GAPDH (housekeeping gene), aggrecan, and collagen type II were designed (Table 1) . One microliter of each RT reaction was used as a template for PCR reactions (35 cycles) in a final volume of 25 µL with 0.2 mM dNTP mix, 20 pmol of each primer, 1.25 U SmarTaq DNA polymerase, 1.5 mM MgCl 2 and 5 µL 10X PCR buffer. Amplified cDNAs were visualized by 1.5% agarose gel electrophoresis and staining with ethidium bromide. The amplification of GAPDH was used as a positive internal control for all samples to verify that the reverse transcription-polymerase chain reactions (RT-PCRs) were successful. Cartilage tissue was used as a positive control.
Statistical analysis
Pellet size data are presented as mean ± SD and were analyzed by analysis of variance (ANOVA) using SPSS 21.0 (IBM Corp., USA), and when ANOVA demonstrated an overall significant effect, differences between means were analyzed using the Bonferroni t-test. The mean data regarding the scoring differentiation were evaluated by Kruskal-Wallis test. P < 0.05 was considered significant.
Results

Cell isolation and expansion
In the first few days of culture, single cells with spindleshaped appearance (Figure 1a) attached to the bottom of the culture flask and began to proliferate after a delay of several days to form colonies around day 7 (Figure 1b) . On days 8 to 10, the cells proliferated as individual colonies with a fibroblast-like morphology. The cells became more elongated within 18 to 21 days of culture with 80% confluency (Figure 1c) . The cells at passage 0 were isolated and subcultured until P3, resulting in a relatively uniform population of fibroblast-like cells.
Confirmation of MSC characteristics
Minimal criteria (De Schauwer et al., 2011; Alipour et al., 2014) for identification of isolated MSCs including sticking to the bottom of the flask, expression of specific markers, and differentiation to adipocytes and osteocytes were evaluated. The isolated cells were plastic-adherent with a fibroblast-like phenotype. The cells exhibited expression of mesenchymal markers (CD29, CD44, and CD90) and not MHC-II and CD34. Moreover, the potential of adipogenic and osteogenic differentiation of cells was confirmed.
Comparison of pellet size in different treatment groups
At the end of the differentiation period, data analysis of pellet size showed that pellet circumference in all treatment groups was larger than that in control group (P < 0.05). Pellet circumference in groups containing growth factor(s) was significantly larger than that in the chondrogenic group without growth factor. Although the largest pellets belonged to the group containing both growth factors, there was no significant difference in pellet size among groups containing either or a mix of the growth factors (Figures 2 and 3) . 3.4. Histological studies using different staining methods Using specific staining methods, different signs of cartilage differentiation were evaluated in studied samples ( Figure  4 ). All treated cells showed different levels of chondrogenic differentiation compared to the control group (P < 0.05). Differentiation score in groups containing TGF-β 3 and both growth factors was significantly greater than that in the chondrogenic group without growth factor and the group with BMP-6. Differentiation score in the group containing both growth factors was insignificantly (P > 0.05) greater than the group with only TGF-β 3 (Table 2) . Hematoxylin and eosin, toluidine blue, Alcian blue, and Masson's trichrome staining revealed that in groups containing TGF-β 3 and both factors, the histological markers of cartilage tissue were present. In the groups with growth factors, the stretched and star-shaped cells had turned into spherical cells, lacunae had formed, glycosaminoglycan and proteoglycans had been deposited, and collagen filaments were present.
Expression of cartilage-specific genes
All treatment groups except the control group showed the expression of aggrecan (in all 3 examined samples). The collagen 2 transcript was not amplified in any of the five groups, indicating that collagen had not been expressed in detectable amounts (Figure 5 ).
Discussion
In veterinary science, stem cell therapy can be used to treat incurable diseases such as articular cartilage and tendon and ligament lesions of expensive racing horses (Alves et al., 2011; Calloni et al., 2014) . Regenerative medicine and tissue engineering is focused on cell therapy with growth factors to repair tissues such as tendons and ligaments (Koch et al., 2007) . The chondrogenic potential of equine MSCs isolated from different sources has been investigated and the prominent effect of cell sources on chondrogenic differentiation potential has been reported (Fortier et al., 1998; Arnhold et al., 2007; Stewart et al., 2007; Giovannini et al., 2008; Vidal et al., 2008; Penny at el., 2012; Burk et al., 2013) . Some studies have determined the best chondrogenic differentiation for bone marrow MSCs (Giovannini et al., 2008; Vidal et al., 2008 , Penny et al., 2012 , whereas others have indicated the prominent differentiation for cord blood MSCs and the weakest differentiation for bone marrow MSCs (Burk et al., 2013) . These controversial findings show that the source of MSCs and culture conditions are two main issues in the therapeutic applications of MSCs. Due to the easier accessibility and higher proliferation competency of AT-MSCs than MSCs from other sources (Niyaz et al., 2012; Penny et al., 2012) , in this study, we tried to focus on the isolation and characterization of equine MSCs from adipose tissue and differentiate them to chondrocytes. In addition, we compared different conditions to optimize chondrogenic differentiation potential of equine AT-MSCs and found that supplementation of chondrogenic medium with BMP-6 or TGF-β 3 and especially with both of them enhanced the potential of these cells for chondrogenic differentiation.
Enhancing the ability of AT-MSCs for chondrogenic differentiation is an interesting subject, as these cells are easily available and abundant in fat tissue. However, their chondrogenic differentiation potential seems to be less than that of MSCs derived from other sources such as bone marrow (Dragoo et al., 2007; Vidal et al., 2008) or cord blood (Burk et al., 2013) . Vidal et al. (2007 Vidal et al. ( , 2008 isolated and characterized equine AT-MSCs and Figure 3 . Pellet circumference measurements. Pellet size in all treated groups is larger than in the control group (P < 0.05). Pellet circumference in groups containing growth factor(s) was significantly larger than in the chondrogenic group without growth factor. There was no statistically significant difference among groups containing growth factors compared to each other. Data are represented as mean ± SD. Different letters (a, b, c) show significant differences. CH: Chondrogenic. differentiated these cells into fat, bone, and cartilage. Their results indicated that the presence of growth factors improved the chondrogenic differentiation of equine ATMSCs (Vidal et al., 2008) . It has also been suggested that TGF-β and dexamethasone are essential but not sufficient for the chondrogenic differentiation of human AT-MSCs. It was also observed that in pellet culture conditions, BMP-6 improves the differentiation of human MSCs into cartilage (Sekiya et al., 2001) . Our findings confirmed that the presence of BMP-6 and TGF-β 3 and especially their combination potentiates chondrogenic differentiation of equine AT-MSCs, in agreement with previous studies. Different studies have used various regimens of growth factors to evaluate the chondrogenic potential of MSCs and especially AT-MSCs (Worster et al., 2000 (Worster et al., , 2001 Estes et al., 2006; Stewart et al., 2007; Somoza et al., 2014) . TGF-β and BMPs are the best candidates to induce chondrogenic phenotype (Tapp et al., 2009 ). BMP-6 induces the expression of TGF-β 1 receptor in micromass culture, and BMP-6 with TGF-β increases the chondrogenic potential of stem cells derived from adipose tissue (Hennig et al., 2007) . TGF-β 3 increases the chondrogenic potential of human bone marrow stem cells due to its putative role in the regulation of cell adhesion molecules, cytokines, and synthesis of cytokine receptors (Hennig et al., 2007) . TGF-β 3 and BMP-6 in human AT-MSCs in alginate culture control the induction of chondrogenesis and increase the mRNA level of collagen type II (Estes et al., 2006) . Henning et al. (2007) acquired similar results for human AT-MSCs and bone marrow MSCs by adding BMP-6 to the culture medium. Cartilage differentiation is accompanied by reducing the expression of collagen type I and increasing the expression of collagen types II, VI, and IX and aggrecan (Dragoo et al., 2007) . Although TGF-β can induce bone marrow MSCs, AT-MSCs require both TGF-β and BMP-6 (Zhang et al., 2010) . In our study, the microscopic appearance of pellets that were grown on medium containing both growth factors showed lacunae and hyaline cartilage formation. This finding was in contrast to the results acquired by Vidal et al. (2008) , who stated that the differentiated pellets had no evidence of lacuna formation and hyaline cartilage. It has been proven that other factors like oxygen tension and culture system affect chondrogenic capability of MSCs. Co et al. (2014) succeeded in increasing the hyaline cartilage production from equine cord blood MSCs in membrane culture at 5% oxygen condition.
In addition to specific staining, chondrogenic differentiation can be confirmed by evaluation of cartilage-specific gene expression. Aggrecan expression, as a cartilage-specific gene, was confirmed in all pellets that were grown on chondrogenic medium with or without growth factors. This finding confirms the results of Dragoo et al. (2007) . Although aggrecan expression was detectable in the BCM group and the group containing BMP-6, the cells did not assume clear chondrocyte morphology in these groups, which shows a limited progression of chondrogenic differentiation. No expression of collagen type II was observed in the treatment groups, while it was present in the positive control (articular cartilage) group. Since the presence of collagen filaments was confirmed by specific staining, lack of amplification of collagen transcript can be contributed to either very low levels of collagen type II transcription in treated groups or likely the transcription of other types of collagen such as types VI and IX.
In conclusion, we found that the addition of BMP-6 and TGF-β 3 alone or together to the conventional chondrogenic medium improves the chondrogenic potential of equine AT-MSCs. Due to the availability and abundance of fat tissue, optimization of the chondrogenic differentiation of AT-MSCs makes them an attractive choice of cells for use in regenerative medicine and tissue engineering.
